Novartis Gains MRSA Product Through Acquisition of Protez Pharmaceuticals
By Helen Scrutton
Pharma Deals Review: Vol 2008 Issue 97 (Table of Contents)
Published: 4 Jun-2008
DOI: 10.3833/pdr.v2008.i97.170 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Novartis gains a superbug-targeting antibiotic through this acquisition of Protez Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS